Boise, Idaho--(Newsfile Corp. - August 1, 2022) - Burst Biologics has begun preparation to file an investigational new drug application on its patented technology platform to support spinal fusions. The company is in the process of taking its advanced tissue technology through the designated regulatory framework in support of the Federal Food...